These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 39059821
1. Staphylococcus aureus response and adaptation to vancomycin. Fait A, Silva SF, Abrahamsson JÅH, Ingmer H. Adv Microb Physiol; 2024; 85():201-258. PubMed ID: 39059821 [Abstract] [Full Text] [Related]
2. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus. Hort M, Bertsche U, Nozinovic S, Dietrich A, Schrötter AS, Mildenberger L, Axtmann K, Berscheid A, Bierbaum G. Microbiol Spectr; 2021 Oct 31; 9(2):e0052821. PubMed ID: 34668723 [Abstract] [Full Text] [Related]
3. Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexes. Malachowa N, Sturdevant DE, Porter AR, Martin G, Martens C, Nair V, Hansen B, Ricklefs S, Jenkins SG, Chen L, Kreiswirth BN, DeLeo FR. Microbiol Spectr; 2024 Aug 06; 12(8):e0048624. PubMed ID: 38916317 [Abstract] [Full Text] [Related]
4. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3. Matsuo M, Cui L, Kim J, Hiramatsu K. Antimicrob Agents Chemother; 2013 Dec 06; 57(12):5843-53. PubMed ID: 24018261 [Abstract] [Full Text] [Related]
7. Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study. Kang YR, Kim SH, Chung DR, Ko JH, Huh K, Cho SY, Kang CI, Peck KR. Antimicrob Resist Infect Control; 2022 Aug 05; 11(1):101. PubMed ID: 35932086 [Abstract] [Full Text] [Related]
8. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013. Huang SH, Chen YC, Chuang YC, Chiu SK, Fung CP, Lu PL, Wang LS, Wu TL, Wang JT. J Microbiol Immunol Infect; 2016 Oct 05; 49(5):701-707. PubMed ID: 26320398 [Abstract] [Full Text] [Related]
12. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S. J Antimicrob Chemother; 2011 Jul 05; 66(7):1594-9. PubMed ID: 21525024 [Abstract] [Full Text] [Related]
16. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing. Chen CJ, Lin MH, Shu JC, Lu JJ. J Antimicrob Chemother; 2014 Feb 05; 69(2):349-54. PubMed ID: 24092658 [Abstract] [Full Text] [Related]
18. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains. Cafiso V, Bertuccio T, Spina D, Purrello S, Campanile F, Di Pietro C, Purrello M, Stefani S. PLoS One; 2012 Feb 05; 7(1):e29573. PubMed ID: 22253738 [Abstract] [Full Text] [Related]